Estimize
Posted - 16 hours ago
Wall St is expecting 0.80 EPS for $LIVN Q4 [Reporting 02/19 BMO]
http://www.estimize.com/intro/livn?chart=historical&metric_name=eps&utm_co
DonCorleone77
Posted - 1 week ago
$LIVN LivaNova announces OSPREY clinical study meets safety/efficacy endpoints LivaNova "announced that it met the primary endpoints for its OSPREY randomized controlled trial, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation. Together with its safety endpoints, the RCT achieved statistical significance of its primary endpoint responder rates1,2 between the treatment arm and the sham arm for the LivaNova aura6000(TM) System. The aura6000 is an implantable hypoglossal neurostimulator intended to treat adult patients with moderate to severe obstructive sleep apnea. In the OSPREY study, apnea-hypopnea index and oxygen desaturation index (ODI) reductions are analyzed as part of the study's secondary endpoints. Comparing median values from baseline to six months with therapy (assessed at the seven-month follow-up visit), OSPREY subjects in the device stimulation group experienced significant reductions in these endpoints as follows: AHI reduced by 66.2% when the median at baseline of 34.3 is compared to the median of 11.6 at six months. ODI reduced by 63.3% when the median at baseline of 34.9 is compared to the median of 12.8 at six months. Once the six-month results analysis is completed, LivaNova will submit the OSPREY clinical data to the U.S. Food and Drug Administration as part of its premarket approval submission for the aura6000 System."
swingingtech
Posted - 2 weeks ago
$LIVN
https://wallstreetwaves.com/livanova-livn-shows-signs-of-oversold-conditions/
healthcareguru
Posted - 10/30/24
$LIVN this is fucking stupid and free $$ down here…buyer all day. Massive upside to 2025 estimates. 👍
DonCorleone77
Posted - 10/30/24
$LIVN LivaNova sees FY24 adjusted EPS $3.30-$3.40, consensus $3.16 Raises FY24 revenue view to up 8.5%-9.5% from %7%-8% on a constant-currency basis. When excluding the impact of the ACS segment wind down, the Company now expects revenue for FY24 up 10%-11% on a constant-currency basis. Foreign currency is now expected to be negligible based on current exchange rates. Sees FY24 adjusted free cash flow $110M-$130M.
DonCorleone77
Posted - 10/30/24
$LIVN LivaNova reports Q3 adjusted EPS 90c, consensus 72c Reports Q3 revenue $318.1M, consensus $300.49M. "LivaNova delivered strong revenue and operating income growth in the Q3," said Vladimir Makatsaria, CEO of LivaNova. "This performance reflects the strength of our team's ongoing execution and steadfast commitment to serving customers and their patients. We look forward to building on this momentum in the Q4 and in 2025, driven by our continued focus on performance, innovation, and talent."
healthcareguru
Posted - 10/30/24
$LIVN see you at $80 by YE24… 🔥🔥🔥🔥🔥
healthcareguru
Posted - 10/30/24
$LIVN HOLY CRAP!!!! Huge blowout beat! 27% EPS beat on 6% sales beat,, FCF guide raised 14%….things gonna be up 40%!!! 🔥🔥😊😍 $IHI $XLV
Estimize
Posted - 10/28/24
Wall St is expecting -1.83% YoY EPS growth for $LIVN in Q3, down from 19.23% in Q2 [Reporting 10/30 BMO]
http://www.estimize.com/intro/livn
WeeklyTrader
Posted - 1 month ago
Bear market vibes for $LIVN! RSI: 66.09% 50-day MA: $48.96 200-day MA: $52.83
BmanCCP
Posted - 1 month ago
$IINN $LIVN
BmanCCP
Posted - 1 month ago
@NASAdude So it is confirmed that it is a pump device only. However, unlike the other systems it can use disposables from 2 major companies… Terumo and $LIVN. The livanova pump head disposable should be FDA cleared for use by EOY. This makes it interesting as the other companies pumps must use their disposables. However, like I said before the disposables are where the money is vs. capital equip purchase. Every hospital I work at is on the hunt for new ECMO device. And there are numerous competitors now. Definitely a head wind but the incoming tech from $IINN if proven and brought to market will be a quantum leap.
RockyTSTH
Posted - 1 month ago
$LIVN $SPY JPMorgan Chief Global Strategist Warns Investors On Risk In Current Environment: Increasingly Queasy That Market Keeps Pricing In A Soft Landing
Stock_Titan
Posted - 09/25/24
$LIVN LivaNova to Announce Third-Quarter 2024 Results
https://www.stocktitan.net/news/LIVN/liva-nova-to-announce-third-quarter-2024-1cidg0ov359b.html
Thestocktraderhubzee
Posted - 08/28/24
WATCHLIST AUG 29 2024
$JWN JP Morgan Maintains Underweight on Nordstrom, Raises Price Target to $20
$AAPL Tigress Financial Maintains Strong Buy on Apple, Raises Price Target to $295
$LIVN Baird Maintains Neutral on LivaNova, Maintains $55 Price Target
$DELL Evercore ISI Group Maintains Outperform on Dell Technologies, Maintains $140 Price Target
$GOGL Jefferies Maintains Hold on Golden Ocean Group, Lowers Price Target to $14.5
Roberto_Claro
Posted - 08/28/24
$LIVN: Working on this new playbook after having studied it for weeks now. Easy money trade taking the right side of the V and trailing with 2-min bar highs. I went low in size here because I have no enough reps and liquidity on this one was not ideal.
CAMDENBEER
Posted - 08/28/24
$LIVN UK stock... gl. MM are in rape mode right now.
DIMOHolder
Posted - 08/28/24
$LIVN wtf just happened?
Thestocktraderhubzee
Posted - 3 months ago
$LIVN Baird Maintains Neutral on LivaNova, Lowers Price Target to $55
NVDAMillionaire
Posted - 07/31/24
$LIVN LivaNova PLC: Executing on Core Strengths, Investing for the Future http://beyondspx.com/2024/07/30/livanova-plc-executing-on-core-strengths-investing-for-the-future/
DonCorleone77
Posted - 07/31/24
$LIVN LivaNova raises FY24 adjusted EPS view to $3.10-$3.20 from $3.05-$3.15 FY24 consensus $3.10. Raises FY24 revenue growth view to up 7%-8% from up 6%-7% on a constant-currency basis, consensus $1.22B. When excluding the impact of the ACS segment wind down, the company now expects revenue for full-year 2024 to grow between 9% and 10% on a constant-currency basis, up from prior view of 8%-9%. Foreign currency is expected to be a 1% headwind based on current exchange rates.
DonCorleone77
Posted - 07/31/24
$LIVN LivaNova reports Q2 adjusted EPS 93c, consensus 78c Reports Q2 revenue $318.6M, consensus $304.21M. "In the second quarter, LivaNova achieved strong revenue and operating income growth," said Vladimir Makatsaria, CEO of LivaNova. "Capitalizing on this momentum to achieve sustainable above-market growth over the long-term remains a key priority. I want to recognize our teams around the world for their continued execution and unwavering commitment to serving patients and customers. I also want to thank the consortium of independent experts who conducted an in-depth review of the RECOVER unipolar study results and supported the development of the path forward for the difficult-to-treat depression program."
epsguid
Posted - 07/31/24
$LIVN reported earnings of $0.93, consensus was $0.66 via @eWhispers #epsbeat http://eps.sh/d/livn
Stock_Titan
Posted - 07/31/24
$LIVN LivaNova Reports Second-Quarter 2024 Results
https://www.stocktitan.net/news/LIVN/liva-nova-reports-second-quarter-2024-kqf2ua5axe8o.html
newsfile_corp
Posted - 07/28/24
https://nfne.ws/217982 $LIVN #Banking #FinancialServices #NASDAQ #Investing
newsfile_corp
Posted - 4 months ago
https://nfne.ws/216766 $LIVN #Banking #FinancialServices #NASDAQ #Investing
Stock_Titan
Posted - 5 months ago
$LIVN LivaNova to Announce Second-Quarter 2024 Results
https://www.stocktitan.net/news/LIVN/liva-nova-to-announce-second-quarter-2024-wbq8qo6iwf3n.html
StockInvest_us
Posted - 5 months ago
Signal alert: $LIVN - Oversold Trend Short (Undervalued) https://stockinvest.us/l/zkxEApktQ3
